Table 2 The association between anti-CarP antibodies and anti-CarP antibodies adjusted for ACPA and anti-CCP2, respectively
Pre-symptomatic individuals a | RA patients b | |||
|---|---|---|---|---|
Antibodies against | OR | 95% CI | OR | 95% CI |
CarP | 7.1 | 3.0-17.0 | 23.2 | 9.8-55.0 |
after adjustments for each antibody: | ||||
CarP | 2.4 | 0.9-6.9 | 3.8 | 1.2-12.2 |
CCP2 | 43.8 | 13.54-141.9 | 125.0 | 37.4-417.7 |
CarP | 3.4 | 1.35-8.8 | 8.1 | 3.02-21.4 |
CEP-1 | 10.0 | 4.67-21.6 | 31.4 | 14.3-69.2 |
CarP | 4.9 | 2.0-12.1 | 16.2 | 6.7-39.0 |
citC1 | 5.1 | 2.23-11.8 | 19.2 | 7.9-46.8 |
CarP | 4.5 | 1.81-11.3 | 9.9 | 3.9-25.3 |
Fibß36-52 | 6.6 | 3.50-12.3 | 17.3 | 8.9-33.6 |
CarP | 6.3 | 2.60-15.3 | 20.9 | 8.8-49.8 |
Fibß62-81a(72) | 6.1 | 2.32-16.1 | 4.9 | 1.7-14.0 |
CarP | 4.6 | 1.86-11.5 | 17.3 | 7.1-42.3 |
Fibß62-81b(74) | 37.6 | 5.11-277.2 | 79.1 | 10.7-586.7 |
CarP | 5.6 | 2.33-13.7 | 14.4 | 6.0-35.0 |
Fibα563-583 | 3.1 | 1.28-7.3 | 7.4 | 3.1-17.5 |
CarP | 6.1 | 2.54-14.8 | 21.3 | 8.9-50.5 |
Fibα580-600 | 1.9 | 0.89-4.2 | 2.1 | 0.87-4.9 |
CarP | 3.8 | 1.51-9.7 | 15.0 | 6.1-36.9 |
Fil307-324 | 12.8 | 5.40-30.3 | 19.2 | 7.9-46.9 |
CarP | 5.9 | 2.42-14.2 | 17.3 | 7.2-41.4 |
Vim60-75 | 2.5 | 1.22-5.2 | 4.0 | 1.9-8.5 |
CarP | 6.2 | 2.58-15.1 | 22.0 | 9.26-52.3 |
Vim2-17 | 3.1 | 1.24-8.0 | 3.6 | 1.333-9.9 |
CarP | 3 | 1.2-8.1 | 12.2 | 4.9-30.4 |
CCP2+ and all ACPA | 7.2 | 4.7-11.2 | 9.7 | 5.7-16.5 |